Elanco Tiergesundheit AG Sustainability Profile
Elanco Tiergesundheit AG, a prominent player in the animal health industry, is headquartered in Switzerland (CH) and operates extensively across Europe and beyond. Founded in 1954, Elanco has established itself as a leader in providing innovative solutions for livestock and companion animals, focusing on improving animal health and welfare. The company offers a diverse range of products and services, including vaccines, pharmaceuticals, and nutritional supplements, all designed to enhance animal productivity and well-being. Elanco's commitment to research and development sets it apart, ensuring that its offerings are both effective and sustainable. With a strong market position, Elanco Tiergesundheit AG has achieved notable milestones, including significant advancements in animal health technologies. The company continues to be recognised for its contributions to the industry, making it a trusted partner for veterinarians and farmers alike.
DitchCarbon Score
How does Elanco Tiergesundheit AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elanco Tiergesundheit AG's score of 71 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elanco Tiergesundheit AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. The company is a current subsidiary of Elanco Animal Health Incorporated, which may influence its climate commitments and reporting practices. While no specific reduction targets or achievements are available for Elanco Tiergesundheit AG, it is important to note that its parent company, Elanco Animal Health Incorporated, is involved in various climate initiatives. These include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific targets or performance metrics from these initiatives have not been disclosed for Elanco Tiergesundheit AG. As a subsidiary, Elanco Tiergesundheit AG may align its climate strategies with those of Elanco Animal Health Incorporated, focusing on sustainability and reducing environmental impact. The lack of detailed emissions data and reduction targets highlights the need for further transparency in their climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Elanco Tiergesundheit AG's Industry?
How Carbon Intensive is Elanco Tiergesundheit AG's Location?
Elanco Tiergesundheit AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elanco Tiergesundheit AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
